BAK BRASKEM SA IFRS
Industrial Organic Chemicals · NYSE · SEC CIK 1071438 · Reporting currency BRL · Fiscal year ends 12/31
Financial factors as of 2023-12-31 (FY2023), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: BRL | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 77.41B | 70.57B |
| Cost of revenue | 71.41B | 67.55B |
| Gross profit | 6.00B | 3.02B |
| R&D expense | 463.00M | 383.00M |
| SG&A expense | 2.64B | 2.47B |
| Operating income | -1.08B | -2.79B |
| Interest expense | 6.85B | 5.59B |
| Pretax income | -17.73B | -6.19B |
| Income tax | -5.68B | -1.30B |
| Net income | -11.32B | -4.58B |
| EBITDA | 3.87B | 2.41B |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | 14.99B | 14.19B |
| Short-term investments | 1.79B | 4.96B |
| Receivables | 3.56B | 2.91B |
| Inventory | 13.69B | 12.53B |
| Current assets | 37.04B | 37.44B |
| PP&E, netmay include right-of-use assets (IFRS) | 40.42B | 38.41B |
| Total assets | 101.58B | 91.74B |
| Current liabilities | 28.27B | 24.49B |
| Short-term debt | 14.28B | 10.51B |
| Long-term debt | 50.95B | 40.21B |
| Total debt | 65.23B | 50.72B |
| Total liabilities | 105.85B | 88.46B |
| Shareholders' equity | -4.78B | 3.99B |
| Net debt | 50.24B | 36.53B |
| Shares outstanding | 797.21M | 797.21M |
| Cash flow statement | ||
| Operating cash flow | 2.44B | -2.27B |
| Capital expenditure | 3.76B | 4.53B |
| Free cash flow | -1.33B | -6.80B |
| Investing cash flow | -3.48B | -4.53B |
| Financing cash flow | 469.00M | 8.87B |
| Depreciation & amortization | 4.95B | 5.21B |
| Dividends paid | 6.00M | 7.00M |
Free plan shows the latest 2 periods; Pro shows all 10 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Amounts are in the company's reporting currency, BRL, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.